Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Nosocomial bloodstream infections are important causes of morbidity and mortality. In this study, concurrent surveillance for nosocomial bloodstream infections at 49 hospitals over a 3-year period detected >10,000 infections. Gram-positive organisms accounted for 64% of cases, gram-negative organisms accounted for 27%, and 8% were caused by fungi. The most common organisms were coagulase-negative staphylococci (32%), Staphylococcus aureus (16%), and enterococci (11%). Enterobacter, Serratia, coagulase-negative staphylococci, and Candida were more likely to cause infections in patients in critical care units. In patients with neutropenia, viridans streptococci were significantly more common. Coagulase-negative staphylococci were the most common pathogens on all clinical services except obstetrics, where Escherichia coli was most common. Methicillin resistance was detected in 29% of S. aureus isolates and 80% of coagulase-negative staphylococci. Vancomycin resistance in enterococci was species-dependent--3% of Enterococcus faecalis strains and 50% of Enterococcus faecium isolates displayed resistance. These data may allow clinicians to better target empirical therapy for hospital-acquired cases of bacteremia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Candida species are the fourth most common cause of hospital-acquired bloodstream infections (BSI) in the United States (5, 9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
In the citing paper
“These species proportions are very similar to those previously reported from the northeastern United States (9).”
In the citing paper
“The National Epidemiology of Mycoses Survey study demonstrated geographic variations in species distributions throughout the United States, with C. albicans ranging from 46% in the northeast to 70% in the southwest and C. glabrata ranging from 15% in the southwest to 26% in the northeast (9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984 · cited 3×
“Nonetheless, prospective surveillance projects such as ours will allow rapid detection of such infections, which initially appeared in Japan [17, 18] and have been reported in the United States [19].”
BackgroundHiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00192-2 · Cited by 424 · cited 1×
“Several subprojects have evaluated samples of organisms from this study and have included validation measures, such as reidentification of species and retesting of antimicrobial susceptibilities in the Special Microbiology Laboratory at the University of Iowa College of Medicine [6–14].”
BackgroundSelf-citationPfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00240-x · Cited by 331
Self-citationCeftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United States
Burwen, D. R., Banerjee, S. N., Gaynes, R. P., & System, T. N. N. I. S. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.6.1622 · Cited by 214
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 203
Jones, R. N., Marshall, S. A., Pfaller, M. A., Wilke, W. W., Hollis, R. J., Erwin, M. E., Edmond, M. B., & Wenzel, R. P. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00115-6 · Cited by 153
Self-citationMarshall, S. A., Wilke, W. W., Pfaller, M. A., & Jones, R. N. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00212-5 · Cited by 146
Self-citationAntimicrobial Resistance: Issues and Options
(1998) · National Academies Press eBooks · doi:10.17226/6121 · Cited by 129
Cited by
Items 701–800 of 1,001
Tacconelli, E., D’Agata, E. M. C., & Karchmer, A. W. (2003) · Clinical Infectious Diseases · doi:10.1086/377207 · Cited by 29
Wilson, S. E. (2001) · Surgical Infections · doi:10.1089/109629601750185334 · Cited by 29
Farina, C., Perin, S., Andreoni, S., Conte, M., Fazii, P., Lombardi, G., Manso, E., Morazzoni, C., & Sanna, S. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02166.x · Cited by 28
Bacteremias em pacientes internados em hospital universitário
Guilarde, A. O., Turchi, M. D., Martelli, C. M. T., Primo, M. G. B., & Batista, L. J. D. A. (2007) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302007000100016 · Cited by 28
Immunotherapy for invasive fungal infections: from bench to bedside
Pappas, P. G. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2003.12.002 · Cited by 28
Sidhu, J. P. S., Skelly, E., Hodgers, L., Ahmed, W., Li, Y., & Toze, S. (2014) · Environmental Science & Technology · doi:10.1021/es4050083 · Cited by 28
Candidemia in the in-patient setting: treatment options and economics
Gagne, J. J., & Goldfarb, N. I. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1643 · Cited by 28
Keim, L. S., Torres-Filho, S. R., Silva, P. V., & Teixeira, L. A. (2011) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822011000100031 · Cited by 28
Doxorubicin induces drug efflux pumps inCandida albicans
Kofla, G., Turner, V., Schulz, B., Storch, U., Froelich, D., Rognon, B., Coste, A. T., Sanglard, D., & Ruhnke, M. (2010) · Medical Mycology · doi:10.3109/13693786.2010.512022 · Cited by 28
Hassan, E. A., Elsherbiny, N. M., El‐Rehim, A. S. E. A., Soliman, A. M. A., & Ahmed, A. O. (2017) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2017.09.006 · Cited by 28
Hiranpattanakul, P., Jongjitpissamai, T., Aungwerojanawit, S., & Tachaboonyakiat, W. (2018) · Research on Chemical Intermediates · doi:10.1007/s11164-018-3344-x · Cited by 28
Regulated Cell Death as a Therapeutic Target for Novel Antifungal Peptides and Biologics
Yeaman, M. R., Büttner, S., & Thevissen, K. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5473817 · Cited by 28
Cunha, & Calsolari, R. A. O. (2008) · Microbiology Insights · doi:10.4137/mbi.s796 · Cited by 28
The Virulence of Human Pathogenic Fungi: Notes from the South of France
Reedy, J. L., Bastidas, R. J., & Heitman, J. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.07.004 · Cited by 28
Lattif, A. A., Chandra, J., Chang, J., Liu, S., Zhou, G., Chance, M. R., Ghannoum, M. A., & Mukherjee, P. K. (2008) · The Open Proteomics Journal · doi:10.2174/1875039700801010005 · Cited by 28
Isolation Frequency Characteristics of Candida Species from Clinical Specimens
Kim, G. Y., Jeon, J., & Kim, J. K. (2016) · Mycobiology · doi:10.5941/myco.2016.44.2.99 · Cited by 28
Critical care unit outbreak of Serratia liquefaciens from contaminated pressure monitoring equipment
Harnett, S. J., Allen, K. D., & Macmillan, R. R. (2001) · Journal of Hospital Infection · doi:10.1053/jhin.2001.0941 · Cited by 28
Bloodstream infections in a secondary and tertiary care hospital setting
Raymond, N. J., Blackmore, T., Humble, M. W., & Jones, M. R. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01213.x · Cited by 28
Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit
Faiz, S. A., Neale, B. W., Ríos, E. V., Campos, T., Parsley, E., Patel, B., & Ostrosky-Zeichner, L. L. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0666-4 · Cited by 28
Badrane, H., Cheng, S., Nguyen, M. H., Jia, H. Y., Zhang, Z., Weisner, N., & Clancy, C. J. (2005) · Microbiology · doi:10.1099/mic.0.27998-0 · Cited by 26
Oral lactoferrin protects against experimental candidiasis in mice
Velliyagounder, K., Alsaedi, W., Alabdulmohsen, W., Markowitz, K., & Fine, D. H. (2015) · Journal of Applied Microbiology · doi:10.1111/jam.12666 · Cited by 27
Buu, L.-M., & Chen, Y.-C. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-101 · Cited by 27
Westwater, C., Schofield, D. A., Nicholas, P. J., Paulling, E. E., & Balish, E. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00287.x · Cited by 27
Lai, C., Chu, C.-C., Wang, C.-Y., Tsai, H.-Y., Cheng, A., Lee, Y., Huang, Y., Liao, C., & Hsueh, P. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.05.024 · Cited by 27
Feistel, D. J., Elmostafa, R., Nguyen, N., Penley, M. J., Morran, L. T., & Hickman, M. A. (2019) · mSphere · doi:10.1128/msphere.00697-18 · Cited by 27
Saleem, M., Nawaz, H., Majeed, M. I., Rashid, N., Anjum, F., Tahir, M. W., Shahzad, R., Sehar, A., Sabir, A., Rafiq, N., et al. (2023) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2023.103278 · Cited by 27
Berger, J., Diab‐Elschahawi, M., Blacky, A., Pernicka, E., Spertini, V., Assadian, O., Koller, W., & Aichberger, K. J. (2010) · American Journal of Infection Control · doi:10.1016/j.ajic.2010.04.212 · Cited by 27
Cox, L. A., Popken, D. A., & Mathers, J. J. (2009) · Risk Analysis · doi:10.1111/j.1539-6924.2009.01202.x · Cited by 27
Eleven-year retrospective survey of candidaemia in a university hospital in southwestern Greece
Spiliopoulou, A., Vamvakopoulou, S., Bartzavali, C., Dimitracopoulos, G. O., Anastassiou, E. D., & Christofidou, M. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03193.x · Cited by 27
Design and synthesis of new fluconazole analogues
Pore, V. S., Agalave, S. G., Singh, P., Shukla, P. K., Kumar, V., & Siddiqi, M. I. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00590f · Cited by 27
Ren, D., & Wood, T. K. (2004) · Environmental Microbiology · doi:10.1111/j.1462-2920.2004.00587.x · Cited by 27
Rahbar, M., Gra-Agaji, R., & Hashemi, S. (2005) · Eastern Mediterranean Health Journal · doi:10.26719/2005.11.3.478 · Cited by 27
Koh, E.-M., Lee, S., Kim, C. K., Kim, M., Yong, D., Lee, K., Kim, J. M., Kim, D. S., & Chong, Y. (2007) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2007.27.4.265 · Cited by 27
Use of Outer Surface Protein Repeat Regions for Improved Genotyping of Staphylococcus epidermidis
Monk, A. B., & Archer, G. L. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02317-06 · Cited by 27
Combination antifungals: an update
Segal, B. H., & Steinbach, W. J. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.5.883 · Cited by 27
Rhomberg, P. R., Fritsche, T. R., Sader, H. S., & Jones, R. N. (2005) · Journal of Chemotherapy · doi:10.1179/joc.2005.17.5.459 · Cited by 27
Self-citationJohnson, A. P., Warner, M., Carter, M., & Livermore, D. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.321-326.2002 · Cited by 27
Vena, A., Bovis, F., Tutino, S., Barbone, A. S., Mezzogori, L., Ponzano, M., Taramasso, L., Baldi, F., Dettori, S., Labate, L., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac656 · Cited by 26
Deck, M. K., Anderson, E. S., Buckner, R. J., Colasante, G., Davis, T. E., Coull, J. M., Crystal, B. S., Latta, P. D., Fuchs, M., Fuller, D., et al. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.12.004 · Cited by 26
Reboli, A. C., Rotstein, C., Kett, D. H., Maschio, M., Cartier, S., Chambers, R. B., & Tarallo, M. (2011) · PharmacoEconomics · doi:10.2165/11584810-000000000-00000 · Cited by 26
Dalle, F., Lafon, I., L’Ollivier, C., Ferrant, E., Sicard, P., Labruère, C., Jébrane, A., Laubriet, A., Vagner, O., Caillot, D., et al. (2008) · Haematologica · doi:10.3324/haematol.11882 · Cited by 26
Han, J. Y., Wiederoder, M. S., & DeVoe, D. L. (2019) · Microsystems & Nanoengineering · doi:10.1038/s41378-019-0063-4 · Cited by 26
Veses, V., Casanova, M., Murgui, A., Domínguez, Á., Gow, N. A. R., & Martínez, J. P. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.6.1088-1101.2005 · Cited by 26
Candidainfections in the intensive care unit: epidemiology, risk factors and therapeutic strategies
Bassetti, M., Righi, E., Tumbarello, M., Biagio, A. D., Rosso, R., & Viscoli, C. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.5.875 · Cited by 26
The Enterobacteriaceae: General Characteristics
Farmer, J. J., Farmer, M. K., & Holmes, B. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0051 · Cited by 26
Díez, A., Carrano, G., Bregón-Villahoz, M., Cuétara, M. S., García‐Ruiz, J. C., Fernandez-de-Larrinoa, Í., & Moragues, M. D. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115509 · Cited by 25
Horn, D., Neofytos, D., Fishman, J. A., Steinbach, W. J., Anaissie, E. J., Marr, K. A., Pfaller, M. A., & Olyaei, A. J. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0383-4 · Cited by 25
Self-citationChakravart, S., & Haleagraha, N. (2010) · Microbiology Journal · doi:10.3923/mj.2011.1.7 · Cited by 25
In vitro activity of five antifungal drugs against Candida albicans isolates in Sari, Iran
Afsarian, S. M. H. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.2.8 · Cited by 25
Epigenetic determinants of phenotypic plasticity in Candida albicans
Rai, L. S., Singha, R., Brahma, P., & Sanyal, K. (2017) · Fungal Biology Reviews · doi:10.1016/j.fbr.2017.07.002 · Cited by 25
Pratikaki, M. E., Platsouka, E. D., Sotiropoulou, C., Douka, E., Paramythiotou, E., Kaltsas, P., Kotanidou, A. N., Paniara, O., Roussos, C., & Routsi, C. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01787.x · Cited by 25
The mycological and molecular study of Hortaea werneckii isolated from blood and splenic abscess
Ng, K. P., Soo‐Hoo, T. S., Na, S. L., Tay, S. T., Hamimah, H., Lim, P. C., Chong, P. P., Seow, H. F., Chavez, A. J., & Messer, S. A. (2005) · Mycopathologia · doi:10.1007/s11046-005-1154-3 · Cited by 25
Candida ParapsilosisSpondylodiscitis after Lumbar Discectomy
Cho, K., Lee, S.-H., Kim, E., & Eoh, W. (2010) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2010.47.4.295 · Cited by 25
Vigilancia de resistencias a los antimicrobianos: estudio VIRA
Picazo, J. J., Betriú, C., Rodríguez-Avial, I., Azahares, E., Sánchez, B. A., & Vira, G. (2002) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(02)72853-x · Cited by 25
Jekarl, D. W., Lee, S., Lee, S., Park, Y.-J., Lee, J., Baek, S. M., An, Y. J., Ock, S. M., & Lee, M. (2012) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21535 · Cited by 25
Antifungal activity of antimicrobial-impregnated devices
Darouiche, R. O., Mansouri, M. D., & Kojic, E. M. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01369.x · Cited by 25
Lautenbach, E., Gould, C. V., LaRosa, L. A., Marr, A. M., Nachamkin, I., Bilker, W. B., & Fishman, N. O. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.09.011 · Cited by 25
Menzin, J., Lang, K. M., Friedman, M., Dixon, D., Marton, J. P., & Wilson, J. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.04004.x · Cited by 25
Walsh, S. M., Kokai‐Kun, J. F., Shah, A., & Mond, J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045227.16829.37 · Cited by 25
Kofla, G., & Ruhnke, M. (2006) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2006.07.011 · Cited by 25
Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium
Tiraboschi, I. N., Bennett, J. E., Kauffman, C. A., Rex, J. H., Girmenia, C., Sobel, J. D., & Menichetti, F. (2000) · Medical Mycology · doi:10.1080/mmy.38.s1.199.204 · Cited by 25
Rationale for the development of immunotherapy regimens against enterococcal infections
Theilacker, C., Krueger, W. A., Kropec, A., & Hüebner, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.08.014 · Cited by 25
Schofield, D. A., Westwater, C., & Balish, E. (2004) · The Journal of Infectious Diseases · doi:10.1086/423856 · Cited by 25
Fungemias en hospitales de la Ciudad de Buenos Aires, Argentina
Moral, L. L., Tiraboschi, I. N., Schijman, M., Bianchi, M., Guelfand, L. I., & Cataldi, S. (2011) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2011.11.001 · Cited by 24
The Candida albicans Rgd1 is a RhoGAP protein involved in the control of filamentous growth
Ness, F., Prouzet‐Mauleon, V., Vieillemard, A., Lefebvre, F., Noël, T., Crouzet, M., Doignon, F., & Thoraval, D. H. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2010.07.007 · Cited by 24
Misidentification of Candida parapsilosis as C famata in a Clinical Case of Vertebral Osteomyelitis
Burton, M. J., Swiatlo, E., & Shah, P. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181f54dab · Cited by 24
Brouwer, C. P. J. M. (2018) · Cohesive Journal of Microbiology & Infectious Disease · doi:10.31031/cjmi.2018.01.000512 · Cited by 24
Global translational landscape of the Candida albicans morphological transition
Mundodi, V., Choudhary, S., Smith, A. D., & Kadosh, D. (2020) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkaa043 · Cited by 24
Aygen, B., Yörük, A., Yýldýz, O., Alp, E., Kocagöz, S., Sümerkan, B., & Doğanay, M. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1198-743x.2004.00855.x · Cited by 24
Kinetic Mechanism of Enterococcal Aminoglycoside Phosphotransferase 2‘ ‘-Ib
Tóth, M., Zajíček, J., Kim, C. K., Chow, J. W., Smith, C. A., Mobashery, S., & Vakulenko, S. B. (2007) · Biochemistry · doi:10.1021/bi6024512 · Cited by 24
A FACS-Optimized Screen Identifies Regulators of Genome Stability in Candida albicans
Loll‐Krippleber, R., Feri, A., Nguyen, M., Maufrais, C., Yansouni, J., d’Enfert, C., & Legrand, M. (2015) · Eukaryotic Cell · doi:10.1128/ec.00286-14 · Cited by 24
Jones, R. N., Jenkins, S. G., Hoban, D. J., Pfaller, M. A., & Ramphal, R. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00125-5 · Cited by 24
Self-citationCandidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis
Jantunen, E., Nihtinen, A., Volin, L., Juvonen, E., Parkkali, T., Ruutu, T., & Anttila, V.-J. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704662 · Cited by 24
Device-related Infections in Children
Shah, S. S., Smith, M. J., & Zaoutis, T. E. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.05.003 · Cited by 24
Horstkotte, M. A., Knobloch, J. K. ‐., Rohde, H., Dobinsky, S., & Mack, D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5041-5046.2004 · Cited by 24
Marra, A. R., Bar, K. J., Bearman, G. M., Wenzel, R. P., & Edmond, M. B. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.08.032 · Cited by 24
Self-citationTreatment of central nervous system infection by vancomycin-resistant enterococcus faecium
Kanchanapoom, T., Koirala, J., Goodrich, J., Agamah, E. S., & Khardori, N. M. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00523-0 · Cited by 24
Antimicrobial Therapy of Sepsis and Septic Shock—When Are Two Drugs Better Than One?
Abad, C. L. R., Kumar, A., & Safdar, N. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.12.001 · Cited by 23
Antifungal Properties of Cationic Phenylene Ethynylenes and Their Impact on β-Glucan Exposure
Pappas, H. C., Sylejmani, R., Graus, M. S., Donabedian, P. L., Whitten, D. G., & Neumann, A. K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00317-16 · Cited by 23
Rast, T. J., Kullas, A. L., Southern, P. J., & Davis, D. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153165 · Cited by 23
Superantigen‐Like Effects of aCandida albicansPolypeptide
Devore‐Carter, D., Kar, S., Vellucci, V. F., Bhattacherjee, V., Domanski, P. J., & Hostetter, M. K. (2008) · The Journal of Infectious Diseases · doi:10.1086/529203 · Cited by 23
Lavin, B. S. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/503171 · Cited by 23
López, H., Li, J. Z., Balan, D. A., Willke, R. J., Rittenhouse, B., Mozaffari, E., Vidal, G., Zitto, T., & Tang, T. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80173-x · Cited by 23
Lim, D. H., Jee, H., Moon, K., Lim, C. S., & Jang, W. S. (2022) · Pathogens · doi:10.3390/pathogens11020111 · Cited by 22
Chen, P., Lo, H., Wu, C.-J., Lee, H., Chang, C., Lee, N., Wang, A.-H., Lin, W.-L., Ko, N., Lee, C., et al. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01818.x · Cited by 22
Johnson, C. M., O’Brien, X. M., Byrd, A. S., Parisi, V., Loosely, A. J., Li, W., Witt, H. A., Faridi, H. M., Lefort, C. T., Gupta, V., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502381 · Cited by 22
Calcium cross-linked zwitterionic hydrogels as antifouling materials
Chan, H., Erathodiyil, N., Wu, H., Lu, H., Zheng, Y., & Ying, J. Y. (2020) · Materials Today Communications · doi:10.1016/j.mtcomm.2020.100950 · Cited by 22
Antifungal Susceptibility Testing
Fothergill, A. W., Rinaldi, M. G., & Sutton, D. A. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.06.008 · Cited by 22
Genitourinary fungal infections: a therapeutic conundrum
Wise, G. J. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.8.1211 · Cited by 22
Polgreen, P. M., Beekmann, S. E., Chen, Y., Doern, G. V., Pfaller, M. A., Brueggemann, A. B., Herwaldt, L. A., & Diekema, D. J. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/501537 · Cited by 22
Self-citationNon-steroidal anti-inflammatory drugs may modulate the protease activity of Candida albicans
Carvalho, A. P., Gursky, L. C., Rosa, R. T., Rymovicz, A. U. M., Campelo, P. M. S., Grégio, A. M. T., Koga‐Ito, C. Y., Samaranayake, L. P., & Rosa, E. A. R. (2010) · Microbial Pathogenesis · doi:10.1016/j.micpath.2010.07.007 · Cited by 22
Monitoring microaerobic denitrification of Pseudomonas aeruginosa by online NAD(P)H fluorescence
Ju, L., Chen, F., & Xia, Q. (2005) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-005-0035-6 · Cited by 22
Phagocytosis of Candida albicans by RNAi-Treated Drosophila S2 Cells
Stroschein, S. L., Foley, E., O’Farrell, P. H., & Johnson, A. D. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-204-5_24 · Cited by 22
Micafungin: the US perspective
Zaas, A. K., & Steinbach, W. J. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.2.183 · Cited by 22
Elaboration of antibiofilm surfaces functionalized with antifungal-cyclodextrin inclusion complexes
Gharbi, A., Humblot, V., Turpin, F., Pradier, C., Imbert, C., & Berjeaud, J. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00932.x · Cited by 21
Plasmid-mediated antibiotic resistance in Staphylococcus aureus from patients and non patients
Daini, O., & Akano, S. A. (2009) · Scientific Research and Essays · doi:10.5897/sre.9000736 · Cited by 21
Yolanda Cifuentes, C., Ruiz, A., Leal, A. L., Muñoz, L., Herrera, M., & Jiménez, L. (2005) · Revista de Salud Pública · doi:10.1590/s0124-00642005000200007 · Cited by 21
Polyadenylation of ribosomal RNA by Candida albicans also involves the small subunit
Fleischmann, J., Liu, H., & Wu, C.-P. (2004) · BMC Molecular Biology · doi:10.1186/1471-2199-5-17 · Cited by 21
Repeated Point Prevalence Survey of Nosocomial Infections in a Greek University Hospital
Starakis, I., Marangos, M. N., Gikas, A. I., Pediaditis, I., & Bassaris, H. P. (2002) · Journal of Chemotherapy · doi:10.1179/joc.2002.14.3.272 · Cited by 21
Tallent, S. M., Bischoff, T., Climo, M. W., Ostrowsky, B. E., Wenzel, R. P., & Edmond, M. B. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.2249-2250.2002 · Cited by 21
Self-citation
Metadata
- Authors
- Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Wenzel, Richard P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08
- Volume
- 29
- Issue
- 2
- Pages
- 239-244
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2157766752
- Cited by
- 1,387
- References
- 16
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 13 · 2023: 13 · 2022: 18 · 2021: 21 · 2020: 23 · 2019: 37 · 2018: 31 · 2017: 36 · 2016: 41 · 2015: 33 · 2014: 56 · 2013: 55 · 2012: 55
- FWCI
- 47.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- nosocomial bloodstream infection, hospital-acquired bacteremia, coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus, Gram-positive bacteria, Gram-negative bacteria, fungemia, methicillin resistance, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, Streptococcus viridans, neutropenia, intensive care unit, empirical antibiotic therapy, infection surveillance
- MeSH terms
- Candida, Cross Infection, Gram-Negative Bacteria, Gram-Positive Bacteria, Hospitals, Humans, Neutropenia, Staphylococcus, United States, Fungemia, Bacteremia, Enterococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.